
Daily aspirin may prevent distant cancer metastasis, according to a recent analysis. Researchers from the United Kingdom examined 5 large, randomized trials (17,285 participants) of daily aspirin (≥75 mg daily) vs control for the prevention of vascular events to assess the effect of aspirin on the frequency of distant metastasis…
Read more »
Risk of bleeding with daily aspirin may offset benefit in low-risk patients
Chronic use of low-dose aspirin, defined as 300 mg/day or less, is associated with an increased risk of major gastrointestinal (GI) or cerebral bleeding, a recent review of administrative data found. Patients with diabetes also were found to have a high rate of bleeding, irrespective of aspirin use. Key Point:…
Read more »